Class 4 caution in use-Co-trimoxazole 80mg/400mg per 5ml adult suspension

Aspen Pharma Trading Limited has informed the MHRA that an error has been found in the Patient Information Leaflet.

MHRA Drug alert date: 25th July 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-aspen-pharma-trading-limited-co-trimoxazole-80mg-slash-400mg-per-5ml-adult-suspension-el-24-a-slash-32?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=81536038-7615-41f4-b4e5-092e1062ba23&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact: Aspenmedinfo@professionalinformation.co.uk,
Tel: 0800 008 7392

Class 4 caution in use-Freeflex/Steriflex No. 11 Hartmann's solution

Fresenius Kabi Limited has informed the MHRA of a labelling error on the packaging of Hartmann’s solution for Injection BP as Steriflex No.11 or freeflex.

MHRA Drug alert date: 24th July 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-fresenius-kabi-limited-hartmanns-solution-for-injection-bp-as-steriflex-no-11-or-freeflex-el-24-a-slash-31?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=266c16df-6328-44c8-bc25-a79181e2bf0f&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For more information or medical information queries please email
Medical.Information-UK@fresenius-kabi.com or telephone +44 (0) 1928533575.

For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758.

Class 2 recall-Flolan 1.5 mg Powder and Solvent for Solution for Infusion

Glaxo Wellcome UK Ltd (GSK) has informed the MHRA that vials of Flolan 1.5 mg Powder and Solvent for Solution for Infusion, batch number AB8M may have been damaged during the packaging process.

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-glaxo-wellcome-uk-limited-trading-as-glaxosmithkline-uk-flolan-1-dot-5-mg-powder-and-solvent-for-solution-for-infusion-el-24-a-slash-30

Further Information

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

For more information on stock and resupply queries, contact your hospital or homecare provider. In the case of NHS trusts please contact 0800 221 441.

Should you have any questions or require additional information, please contact GSK Medical Information Department at ukmedinfo@gsk.com or alternatively contact 0800 221 441.

Alliance Healthcare UK to enter into a new solus agreement with Flynn Pharma: 01 August 2024

We are pleased to announce that, as of 01 August 2024, Alliance Healthcare UK will become the only wholesaler to supply selected products of Flynn Pharma’s product portfolio to all pharmacies, hospital pharmacies, and doctors in the United Kingdom, including Northern Ireland.

Click here for full product details.

Class 2 recall-Pemetrexed 100mg/1100mg Infusion bag

Sun Pharmaceutical Industries Europe B.V. is recalling the listed batches as a precautionary measure due to visible particulate matter during stability testing.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-sun-pharma-uk-limited-pemetrexed-1000mg-slash-100ml-10mg-slash-ml-and-1100mg-slash-100ml-11mg-slash-ml-infusion-bag-el-24-a-slash-29?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=072b40d3-df8c-47dd-a6b7-6c15a2e30f34&utm_content=immediately

Further Information

For medical information enquiries please contact, medinfoeurope@sunpharma.com.

For stock control enquiries please contact Sun Pharma Customer Service, Cserv.uk@sunpharma.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Gemcitabine PPF 1800mg/180mL Infusion; Gemcitabine PPF 1600mg/160mL Infusion; Irinotecan PPF 360mg/240mL Infusion

Sun Pharma UK Ltd is recalling certain batches as a precautionary measure due to a small number of leaks found intermittently in the infusion bags.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-sun-pharma-uk-limited-gemcitabine-ppf-1800mg-slash-180ml-infusion-gemcitabine-ppf-1600mg-slash-160ml-infusion-irinotecan-ppf-360mg-slash-240ml-infusion-el-24-a-slash-28?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d2d18634-9729-4c08-ab73-4f5410162e11&utm_content=immediately

Further Information

For medical information enquiries please contact, medinfoeurope@sunpharma.com.

For stock control enquiries please contact Sun Pharma Customer Service, Cserv.uk@sunpharma.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Propantheline Tablets 15mg (Genesis Pharmaceuticals livery)

Chelonia Healthcare Limited has informed the MHRA that an error relating to the product description was identified in the Patient Information Leaflet (PIL) for the batches listed in this notification.

MHRA Drug alert date: 9th July 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-chelonia-healthcare-limited-propantheline-tablets-15mg-genesis-pharmaceuticals-livery-el-24-a-slash-27?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f28f044e-ba2e-41cd-8103-d934702d907b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For stock control queries please contact info@genesis-pharma.com (Tel 020 7201 0400)

For Medical queries please contact eupvg@genreg.eu (Tel: 020 7201 0421).

Class 2 recall-Itraconazole 10mg/ml Oral Solution

Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or clusters of crystals.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-kent-pharma-uk-itraconazole-10mg-slash-ml-oral-solution-el-24-a-slash-26?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f48bd582-6f15-4f98-9b73-467a2563cd4e&utm_content=immediately

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.services@kent-athlone.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-Atomoxetine capsules (all strengths, Accord livery)

Accord Healthcare Ltd is recalling various batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-atomoxetine-10mg-18mg-25mg-40mg-60mg-80mg-100mg-hard-capsules-el-24-a-slash-25?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=15af204d-8a5a-40bb-91f9-12e8776e19d9&utm_content=immediately

Further Information

For medical information enquiries please contact Accord-UK Ltd Medical Information Department on 01271 385257

For stock control enquiries please contact Accord- UK Ltd Customer Services Team on 0800 373573. 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Alliance Healthcare and Alloga Raise £10,000 for Charity Through Jurassic Coast Challenge

Teams from Alliance Healthcare and Alloga have successfully raised £10,000 for Action Medical Research following the Race the Sun Jurassic Coast Challenge 2024, involving over 30 dedicated team members from across the business.

Participants tackled a 27-mile cycle, a 2-mile canoe, and a 9.6-mile hike along the scenic Jurassic Coast. For the first time, team members also had the option to participate solely in the 9.6-mile hike, making the event more inclusive and encouraging wider participation.

The participants hailed from various locations within the organisation, including the Alloga warehouse team, Preston Service Centre warehouse team, Exeter Service Centre drivers, and Support Office teams at Chessington, showcasing the unity and collaborative spirit of Alliance Healthcare. Their combined efforts and dedication to the cause were instrumental in reaching the fundraising goal.

Sam Unsworth, Head of Communications at Alliance Healthcare and a participant in the event said: "Being part of such a significant challenge for a noble cause has been an incredible experience. The determination and teamwork displayed by everyone has been inspiring. I'm proud that so many team members have come together once again to raise much needed funding for Action Medical Research.”

Lucy Holloway, Corporate Events Fundraiser at Action Medical Research, said: "We are immensely grateful for the continued support from Alliance Healthcare UK. The funds raised will go a long way in supporting our mission to save and change children’s lives through medical research.”

The Race the Sun Jurassic Coast Challenge 2024 not only highlights the physical endurance and dedication of Alliance Healthcare and Alloga team members, but also underscores the company's commitment to creating healthier futures through fundraising for charitable causes and community support.